Related Experiment Videos
Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock
The Bulletin of Tokyo Medical and Dental University
|June 1, 1983
Summary
This study shows that thromboxane A2 (TXA2) plays a role in canine endotoxin shock, influencing late coagulopathy and pulmonary vascular resistance. Reduced glutathione (GSH) partially mitigated TXA2
Area of Science:
- Physiology
- Pharmacology
- Biochemistry
Background:
- Prostaglandins are implicated in endotoxin shock pathophysiology.
- The specific role of thromboxane A2 (TXA2) remains unclear.
Purpose of the Study:
- Investigate the role of TXA2 in canine endotoxin shock.
- Evaluate the therapeutic potential of reduced glutathione (GSH).
Main Methods:
- Measured plasma thromboxane B2 (TXB2) levels via radioimmunoassay.
- Administered E. coli endotoxin and GSH to canines.
- Monitored physiological parameters including arterial pressure and lactic acidemia.
Main Results:
- Plasma TXB2 levels significantly increased post-endotoxin, with a slight reduction in the GSH group.
- TXA2 correlated with late coagulopathy and pulmonary vascular resistance, not early thrombocytopenia or hypertension.
- GSH suppressed lactic acidemia but caused a greater decrease in mean arterial pressure.
- GSH showed a tendency to inhibit increased serum beta-glucuronidase activity.
Conclusions:
- TXA2 is involved in late-stage endotoxin shock complications.
- GSH offers partial mitigation of TXA2 effects and suppresses lactic acidemia.
- GSH's impact on mean arterial pressure warrants further investigation.